vaccine development Archives - Amazing Health Advances

Yale Study Finds Spike Proteins from COVID Jabs Persist for TWO YEARS: Are mRNA Vaccines Rewriting Human DNA?

The AHA! Team — Mon, 17 Feb 2025 06:06:15 +0000

Lance D Johnson via Natural News – Researchers find spike proteins in vaccinated individuals TWO YEARS after inoculation. Yale scientists find COVID spike protein in vaccinated individuals up to two years post-vaccination. Study suggests mRNA genetic material may integrate with human DNA, activating protein-making structures. Renowned scientist Dr. Akiko Iwasaki, who initially supported mRNA vaccines, now leads the study. Vaccine skeptics warn of DNA contamination risks, citing evidence of self-replicating mRNA and reverse transcription. Research reveals mRNA vaccines may induce chronic inflammation, blood clotting, and neurological damage. Findings challenge claims of temporary, localized mRNA effects, raising concerns about long-term health impacts. Evidence suggests vaccinated individuals may become “super spreaders” of spike proteins, potentially endangering public health. Researchers find spike proteins in vaccinated individuals TWO YEARS after inoculation Scientists are raising alarms about the long-term consequences of these experimental COVID-19 injections. New findings from Yale University suggest that the genetic material in mRNA vaccines may not only persist in the human body but could also integrate with human DNA, fundamentally altering our genetic code. This disturbing discovery has profound implications for the health of billions of people worldwide and raises urgent questions about the ethics and safety of mRNA vaccine technology. Yale researchers have identified COVID spike proteins in the blood of vaccinated individuals — up to two years after they received their shots. Crucially, these individuals were never infected with the virus, as confirmed by antibody tests. The immune system typically destroys newly produced spike proteins, but the persistence of these proteins suggests that some vaccinated individuals may be producing them independently. A plausible explanation is that the genetic material delivered by the vaccines has integrated with human genes, activating protein-making structures within cells. If confirmed, this would mark a seismic shift in our understanding of mRNA vaccine safety. The implications of this discovery are staggering. More than a billion people worldwide have received mRNA COVID vaccines, and the possibility that these vaccines are altering human DNA is a game-changer. The consequences could extend far beyond the immediate health risks of Covid-19, potentially leading to chronic inflammation, autoimmune disorders, and long-term organ damage. The spike proteins produced by these vaccines are not benign; they are known to cause blood clotting, neurological inflammation, and even prion-like formations in the brain, which are linked to Alzheimer’s disease. The lead researcher on this groundbreaking study is Dr. Akiko Iwasaki, a renowned immunologist and former president of the American Association of Immunologists. Dr. Iwasaki was once a vocal advocate for mRNA vaccines, dismissing concerns about their safety as “absurd.” However, her team’s findings now suggest that those concerns may have been valid all along. The study, known as LISTEN, began in 2022 and has enrolled approximately 3,000 participants who reported post-vaccine injuries. The researchers have found spike proteins in participants’ blood samples more than 700 days after their last mRNA shot, a finding that challenges the narrative of temporary, localized mRNA effects. Welcome to the dark side of transhumanism The possibility of genetic integration is not a new concern among vaccine skeptics. Some researchers have long warned that the mRNA vaccines could contaminate human DNA, a process known as “transfection.” The manufacturing process of mRNA vaccines involves the use of DNA plasmids, which can lead to small amounts of DNA contamination in the final product. While federal standards limit allowable DNA contamination to 10 nano grams per dose, the lipid nanoparticles used to protect the mRNA may also shield the DNA contaminants, potentially allowing them to integrate into human genes. Recent research by Kevin McKernan and others has provided further evidence of DNA contamination in vaccine vials, raising questions about the adequacy of current regulatory standards. Dr. Richard M. Fleming, a nuclear cardiologist, has also warned that mRNA vaccines are self-replicating and may turn individuals into “never-ending spike protein factories.” His research suggests that the genetic sequence for SARS-CoV-2 is designed to self-assemble and self-amplify, integrating into human DNA through reverse transcription. This process could hijack healthy genetic expression, leading to chronic inflammation and organ damage for years to come. The consequences of these findings are nothing short of alarming. Vaccinated individuals may not only suffer long-term health consequences but could also become “super spreaders” of spike proteins, potentially endangering public health for generations. The idea that mRNA vaccines could rewrite human DNA and turn individuals into perpetual bioweapon vectors is a chilling prospect, one that aligns with the emerging field of transhumanism. As genetic updates become the norm, the line between human and machine blurs, raising ethical questions about autonomy, consent, and the future of humanity. Sources include: AlexBerensen.substack.com Medicine.Yale.edu NaturalNews.com To read the original article, click here

The post Yale Study Finds Spike Proteins from COVID Jabs Persist for TWO YEARS: Are mRNA Vaccines Rewriting Human DNA? appeared first on Amazing Health Advances.

Merck Faces New Controversy Over Mumps Shot Development Practices

The AHA! Team — Wed, 06 Nov 2024 06:03:10 +0000

Patrick Tims via NaturalHealth365 – Merck is back in the spotlight, facing serious accusations over how it developed its latest mumps shot. Merck is back in the spotlight, facing serious accusations over how it developed its latest mumps shot. According to recently released legal documents, the drugmaker may have cut corners in its rush to bring the shot to market, potentially putting children’s health at risk. Concerns are growing that these actions may compromise vaccine safety and reflect broader issues within the company’s development practices. Merck’s latest mumps shot comes under fire Alarming reports claim Merck’s shot contains up to 4 times the approved amount of live virus – up to 600,000 viral particles per dose, compared to the FDA’s recommendation of 160,000. Shockingly, immunity can be triggered with just 20,000 particles. Some even accuse Merck of intentionally inflating the amount of live virus to falsely boost the vaccine’s “effectiveness,” all while failing to conduct proper safety tests. What’s worse, the company appears to have gone to great lengths to hide these practices from regulators. Despite these concerning findings, health agencies and the government have yet to take action to address or halt the vaccine’s distribution. Rewind time back to 2010, and Merck employees filed a lawsuit claiming the company’s mumps vaccine had 400% of the approved concentration level of the virus. The drugmaker’s whistleblowers filed the lawsuit under the False Claims Act. The insinuation is that Merck overfilled its mumps shots for 12-18-month-olds with many times the approved level of the live mumps virus, opting for passive surveillance instead of transparency. Such passive surveillance took the form of parents’ reports detailing kids’ reactions to the jabs. Other shots facing serious scrutiny Merck’s mumps shot is just the latest in a growing list of shots facing serious scrutiny. Alarming reports have emerged about other jabs, raising concerns about transparency, safety, and rushed approvals. The flu shot, for instance, has been criticized for inconsistent effectiveness, leaving many to question why it’s still pushed so aggressively each year despite these flaws. The COVID-19 shots, fast-tracked under emergency use, are another example. Critics argue that the long-term effects are still unknown, and the lack of comprehensive safety data raises red flags. Whistleblower accounts and legal documents suggest that pharmaceutical giants may have prioritized speed and profit over rigorous safety standards, potentially compromising the health of millions. Parents have every reason to be cautious. With so many unanswered questions and unsettling information coming to light, it’s crucial to dig deeper, research the ingredients, and understand what’s really going into these vaccines before making decisions about your child’s health. Protect your child with a holistic approach to well-being As a parent, you should do your due diligence – research the shots, understand the ingredients, and explore all available information. In addition to informed decision-making, you can naturally support your child’s immune system. Ensure they follow a balanced diet rich in organic fruits, vegetables, and other nutrient-dense foods. Encourage healthy habits like getting at least 7 – 9 hours of sleep, practicing good hygiene, regular physical activity, and stress management techniques. Natural immune boosters, including foods like leafy greens, berries, citrus fruits, legumes, seeds, and nuts, can provide valuable support. You might also consider incorporating daily probiotics for gut health and herbs like elderberry or echinacea. However, always consult a holistic healthcare provider before introducing new supplements or herbal remedies into your child’s routine. Sources for this article include: Childrenshealthdefense.org Childrenshealthdefense.org Childrenshealthdefense.org Justice.gov To read the original article click here.

The post Merck Faces New Controversy Over Mumps Shot Development Practices appeared first on Amazing Health Advances.

2nd Coronavirus Vaccine Shows Early Success in US Tests

AHA Publisher — Tue, 17 Nov 2020 08:00:10 +0000

Associated Press via CBN News – For the second time this month, there’s promising news from a COVID-19 vaccine candidate: Moderna said Monday its shots provide strong protection, a dash of hope against the grim backdrop of coronavirus surges in the U.S. and around the world. Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from the company’s still ongoing study. A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective – news that puts both companies on track to seek permission within weeks for emergency use in the U.S. Dr. Stephen Hoge, Moderna’s president, welcomed the “really important milestone” but said having similar results from two different companies is what’s most reassuring. “That should give us all hope that actually a vaccine is going to be able to stop this pandemic and hopefully get us back to our lives,” Hoge told The Associated Press. “It won’t be Moderna alone that solves this problem. It’s going to require many vaccines” to meet the global demand, he added. A vaccine can’t come fast enough, as virus cases topped 11 million in the U.S. over the weekend – 1 million of them recorded in just the past week. The pandemic has killed more than 1.3 million people worldwide, more than 245,000 of them in the U.S. Still, if the Food and Drug Administration allows emergency use of Moderna’s or Pfizer’s candidates, there will be limited, rationed supplies before the end of the year. Both require people to get two shots, several weeks apart. Moderna expects to have about 20 million doses, earmarked for the U.S., by the end of 2020. Pfizer and its German partner BioNTech expect to have about 50 million doses globally by year’s end. Moderna’s vaccine, created with the National Institutes of Health, is being studied in 30,000 volunteers who received either the real vaccination or a dummy shot. On Sunday, an independent monitoring board broke the code to examine 95 infections that were recorded starting two weeks after volunteers’ second dose – and discovered all but five illnesses occurred in participants who got the placebo. The study is continuing, and Moderna acknowledged the protection rate might change as more COVID-19 infections are detected and added to the calculations. Also, it’s too soon to know how long protection lasts. Both cautions apply to Pfizer’s vaccine as well. But Moderna’s independent monitors reported some additional, promising tidbits: All 11 severe COVID-19 cases were among placebo recipients, and there were no significant safety concerns. The main side effects were fatigue, muscle aches and injection-site pain after the vaccine’s second dose, at rates that Hoge characterized as more common than with flu shots but on par with others such as shingles vaccine. Moderna shares rocketed higher on the announcement and appeared to be headed for an all-time high Monday. The Cambridge, Massachusetts, company’s vaccine is among 11 candidates in late-stage testing around the world, four of them in huge studies in the U.S. Both Moderna’s shots and the Pfizer-BioNTech candidate are so-called mRNA vaccines, a brand-new technology. They aren’t made with the coronavirus itself, meaning there’s no chance anyone could catch it from the shots. Instead, the vaccine contains a piece of genetic code that trains the immune system to recognize the spiked protein on the surface of the virus. The strong results were a surprise. Scientists have warned for months that any COVID-19 shot may be only as good as flu vaccines, which are about 50% effective. Another steep challenge: distributing doses that must be kept very cold. Both the Moderna and Pfizer shots are frozen but at different temperatures. Moderna announced Monday that once thawed, its doses can last longer in a refrigerator than initially thought, up to 30 days. Pfizer’s shots require long-term storage at ultra-cold temperatures. Copyright 2020 The Associated Press. All rights reserved. To read the original article click here. For more articles from CBN News click here.

The post 2nd Coronavirus Vaccine Shows Early Success in US Tests appeared first on Amazing Health Advances.

Antiparasitic Drug Ivermectin Kills Coronavirus in 48 Hours

AHA Publisher — Wed, 08 Apr 2020 07:00:16 +0000

Editor’s Note: We published this article to our website and through our email list at the beginning of the COVID-19 Pandemic, in April of 2020 — well before the highly publicized debate over this drug’s effectiveness. It must be noted that the results of this test were done in vitro. Please see the hyperlinks at the end of this article for further studies. Angela Betsaida B. Laguipo, BSN via News-Medical– Around the world, scientists race to develop a vaccine or treatment against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, a team of researchers has found that a drug already available around the world can kill the coronavirus in a lab setting in just 48 hours. The drug, Ivermectin, an antiparasitic medicine, is an inhibitor of the virus SARS-CoV-2 in-vitro and can effectively cause a reduction in virus at 48 hours in cell cultures. The FDA-approved drug can be used for repurposing to treat patients affected by COVID-19, which has spread to 184 countries and territories. The researchers at Monash University in Melbourne, Australia, have published their study in the journal Antiviral Research, showing how this already widely-used drug may help combat the current global pandemic rippling across continents. Reduced COVID-19 Viral RNA The team worked with the Peter Doherty Institute of Infection and Immunity. They showed that Ivermectin reduced COVID-19 viral RNA present in cell culture by as much as 93 percent after 24 hours and by 99.8 percent after 48 hours, at around a 5,000-fold reduction in coronavirus RNA, hinting that the medicine can potentially eradicate the virus. “”We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours, there was a significant reduction in it,” Dr. Kylie Wagstaff of the Monash Biomedicine Discovery Institute, said. “Ivermectin is very widely used and seen as a safe drug. We need to figure out now whether the dosage you can use it in humans will be effective – that’s the next step,” Dr. Wagstaff added. The researchers, however, cautioned that the tests performed in the study were in vitro, and human trials are still needed to determine the efficacy and safety of the drug against the coronavirus. Ivermectin has also shown effectiveness in vitro against a wide range of other viruses, such as the influenza virus, Zika virus, and the human immunodeficiency virus (HIV). Repurposing Ivermectin Ivermectin is an approved drug to treat parasitic conditions, such as rosacea, head lice, and scabies. It was developed in 1975 and has been widely used across the globe since the early 1980s. “In times when we’re having a global pandemic, and there isn’t an approved treatment, if we had a compound that was already available around the world, then that might help people sooner. Realistically, it’s going to be a while before a vaccine is broadly available,” Dr. Wagstaff explained. Though the mechanism of action by which Ivermectin works on the coronavirus is still unknown, the drug works on other viruses by stopping them from inhibiting down the host cells’ ability to detect and fight them. Ivermectin, therefore, warrants further investigation for possible benefits in humans. Further trials should be performed to make sure the drug is effective. If it is effective on humans with coronavirus, it can be widely used to treat affected populations since it already went through approval by the U.S. Food and Drug Administration (FDA). Countries Grapple Against COVID-19 Many countries are unprepared for the coming of the coronavirus disease, which has emerged in China in December 2019. Since then, it has spread to most countries across the globe, touching all continents except Antarctica. The United States reports the highest infections, with more than 368,000 people affected by the virus. It has a staggering 10,923 deaths. Italy has the highest number of deaths, with its death toll reaching 16,523, while Spain has more than 136,000 confirmed cases and 13,341 deaths. Canada has more than 16,000 confirmed cases, while Germany, France, and China have more than 103,000, 98,000, and 82,000 cases, respectively. The coronavirus has dramatically affected the United Kingdom and Australia also, with more than 52,000 and more than 5,700 cases, respectively. This article has been modified. To read the original article click here. Further articles to review regarding Ivermectin: The FDA-Approved Drug Ivermectin Inhibits the Replication of SARS-CoV-2 in Vitro Use of Ivermectin in the Treatment of Covid-19: A Pilot Trial Ivermectin Obliterates 97 Percent of Delhi Cases Why Is the FDA Attacking a Safe, Effective Drug?

The post Antiparasitic Drug Ivermectin Kills Coronavirus in 48 Hours appeared first on Amazing Health Advances.